Correction to Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental
Advanced Materials (Deerfield Beach, Fla.)
|May 27, 2024
Abstract
No abstract available in PubMed .
More Related Videos
08:38Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Published on: April 9, 2012
20.4K
05:55Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
808
